Defence Therapeutics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 Burrard St 1680, Vancouver, British ...Phone Number
(514) 947-2272Website
www.defencetherapeutics.comRevenue
$5.1 MillionStock Symbol
DTCFFIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Defence Therapeutics
Defence Therapeutics is a publicly traded company specializing in precision intracellular drug delivery, focusing on enhancing the efficacy of cancer biologics through its proprietary Accum platform. The company aims to improve the potency and safety of antibody-drug conjugates (ADCs), radiopharmaceuticals, and other advanced therapies, making them more effective first-line treatments. With a strong intellectual property portfolio and a pipeline that includes partnerships for licensing and co-development, Defence Therapeutics is positioned to capitalize on the growing oncology market. Their vision is to ensure that every cancer therapy achieves its full potential, ultimately transforming patient outcomes worldwide.Explore more
Defence Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Defence Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Defence Therapeutics had a recent Job posting/layoffs
Defence Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Defence Therapeutics
Check if Defence Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Defence Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Defence Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Defence Therapeutics has new funding data
Earning: See what the market has to say on Defence Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Defence Therapeutics
Compare insights from companies similar to Defence Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$6.3M
11-50
Private
<$5M
2015
KT
Kevin ThompsonExecutive VP, Finance & Interim Chief Financial Officer, Accounting
Company Profile Activity
Activity Insights
Defence Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Defence Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Defence Therapeutics.
Defence Therapeutics Tech Stack
A closer look at the technologies used by Defence Therapeutics
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Business Development, Operations
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Defence Therapeutics News & Media
Defence Therapeutics opens Hamilton office for radiopharma | DTCFF Stock News
New office at McMaster Innovation Park supports radiopharmaceutical research and business development as Defence expands its Accum platform.Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to ...
Montreal, Quebec--(Newsfile Corp. - June 3, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"),...Defence Therapeutics Appoints Antibody Drug Conjugates Pioneer Dr. John Lambert to Its ...
Montreal, Quebec--(Newsfile Corp. - June 1, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Defence Therapeutics
Sign Up For FreeTo access detailed company insights
Defence Therapeutics is a publicly traded company specializing in precision intracellular drug delivery, focusing on enhancing the efficacy of cancer biologics through its proprietary Accum platform. The company aims to improve the potency and safety of antibody-drug conjugates (ADCs), radiopharmaceuticals, and other advanced therapies, making them... Read More
